Thought Leadership
Search results
Blog | October 20, 2016
Biogen Dodges IPR Bullet on Key Tysabri® Patents
Read more
Blog | October 07, 2016
Amgen Appeals Loss of Neulasta® and Neupogen® Litigation
Read more
Blog | September 30, 2016
Court Orders Entry of Final Judgment of Invalidity in Ongoing Janssen v. Celltrion BPCIA Dispute
Read more
Blog | September 21, 2016
FDA to Hold Public Meeting on Biosimilar User Fees
Read more
Blog | September 16, 2016
My Intellectual Property Licensor is Bankrupt — Now What?
Read more
Blog | August 11, 2016
Apotex Takes Aim at Amgen Patent in IPR Petition After Being Sued Under the BPCIA
Read more
Blog | July 27, 2016
Federal Circuit Explains Burden Shifting in IPRs
Read more
Blog | July 25, 2016